Evidence map›Paper›PMID 40430181›Full record

ArticleLife (Basel, Switzerland)2025

Creation of Genetically Modified Adipocytes for Tissue Engineering: Creatine Kinase B Overexpression Leads to Stimulated Glucose Uptake and Mitochondrial Potential Growth, but Lowered Lipid Synthesis.

Svetlana Michurina, Irina Beloglazova, Margarita Agareva, Natalia Alekseeva, Yelena Parfyonova, Iurii Stafeev

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Svetlana MichurinaChazov National Medical Research Centre for Cardiology, Moscow 121552, Russia.
Irina BeloglazovaChazov National Medical Research Centre for Cardiology, Moscow 121552, Russia.ORCID 0000-0002-2345-3681
Margarita AgarevaChazov National Medical Research Centre for Cardiology, Moscow 121552, Russia.ORCID 0000-0002-9603-9780
Natalia AlekseevaFaculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia.
Yelena ParfyonovaChazov National Medical Research Centre for Cardiology, Moscow 121552, Russia.
Iurii StafeevChazov National Medical Research Centre for Cardiology, Moscow 121552, Russia.ORCID 0000-0003-3514-3936

Funding

Russian Science Foundation 22-75-10085
6 · The paper itself

Abstract

backgroundThe global burden of obesity and type 2 diabetes mellitus is a significant contributor to mortality and disability in the modern world. In this regard, the modification of adipocyte metabolism has been identified as a promising approach to develop new genetic and cellular engineering therapeutics. In this study, we activate the expression of creatine kinase B (CKB), a key enzyme of a non-canonical futile cycle and the regulator of energy storage, to promote catabolic processes in mature adipocytes.

methodsThe protein-coding sequence of CKB was amplified by PCR from

resultsAfter lentiviral delivery of the CKB-coding sequence, CKB mRNA level increased 75-fold and protein expression fivefold. CKB overexpression does not cause significant changes in lipid droplet morphology. Despite this, enhanced glucose uptake and reduced lipid synthesis under adrenergic stimulation are detected during CKB overexpression. CKB causes an increase in mitochondrial potential with no effect on thermogenesis in adipocytes.

conclusionsIn this study, we have shown that CKB overexpression in mature adipocytes allows us to obtain adipocytes with high glucose uptake, potency of ATP synthesis, and suppressed lipogenesis. These genetically modified cells may potentially exhibit a favorable metabolic effect in the context of excessive nutrient utilization.

Indexed as

adipocytescreatine kinase Bglucose metabolismlipid metabolismthermogenesis

Identifiers

PMID40430181
PMCPMC12113200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.